Galym Zhunisbekov Galym Zhunisbekov Galym Zhunisbekov, a Regional Regulatory Affairs Manager in Eastern Europe, reflects on our philosophy and our impact on millions of lives.
Meet the BD&L Team 2019 Meet the BD&L Team 2019 Hear from our team and find out more about our approach to partnering.
Systemic sclerosis physician video Systemic sclerosis physician video In this video Professor Chris Denton (Consultant Rheumatologist) discusses his experience diagnosing systemic sclerosis, also known as scleroderma
Lamb-shanks video Lamb-shanks video This succulent, heart dish is packed full of flavour and sure to be a hit with the whole family.
Central Nervous System Diseases Central Nervous System Diseases Find out more about our research and development in central nervous system diseases
Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | NSCLC Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | NSCLC Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | NSCLC
Five ways to include more diversity in clinical trials Five ways to include more diversity in clinical trials
Animal Health Partnering Interests Infectious Diseases May 2024 CORP Animal Health Partnering Interests Infectious Diseases May 2024 CORP
Animal Health Partnering Interests Pain & Mobility May 2024 CORP Animal Health Partnering Interests Pain & Mobility May 2024 CORP
Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP
2024 MORE GREEN infographic - Environmental Stewardship at Boehringer Ingelheim 2024 MORE GREEN infographic - Environmental Stewardship at Boehringer Ingelheim
Defining underserved communities_Infographic_230627.pdf Defining underserved communities_Infographic_230627.pdf
Partnering in Infectious Diseases MAY 2024 CORP_0.pdf Partnering in Infectious Diseases MAY 2024 CORP_0.pdf
Partnering with Boehringer Ingelheim MAY 2023 Corp Partnering with Boehringer Ingelheim MAY 2023 Corp
Defining underserved communities_Infographic_230627.pdf Defining underserved communities_Infographic_230627.pdf
Infographic_Defining underserved communities_230627.pdf Infographic_Defining underserved communities_230627.pdf
Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf